Despite Sally Beauty Holdings' reinvestment, returns are shrinking and the stock has dropped 28% in five years. The declining ROCE trend and underlying trends do not inspire confidence in the stock's potential.
Specialty retail stocks have held their ground better than others, with share prices up 17.1% on average since the previous earnings results. However, the performance of individual stocks varied significantly.
Sally Beauty Holdings' low P/E ratio suggests it may not keep up with market growth. Without improved earnings predictions, shares may not rise significantly.
Market's caution toward the business is evident in its low P/E ratio of 5.59. Lingering issues may be indicated by the shares' performance. Contrarian investors could be intrigued, yet warning signs with the stock should also be noted during investment.
Despite solid ROE, Sally Beauty Holdings' substantial debt reliance raises red flags. The high returns, while good, come with increased risk brought by notable debt levels. Complete review of the financial performance and growth rates is mandatory for investment consideration.
Gainers: •$Akero Therapeutics(AKRO.US)$+9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million) •$BrightSpire Capital(BRSP.US)$+6.3% (increases dividend) •$Humanigen(HGEN.US)$+4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom) •$艾里逊变速箱(ALSN.US)$+2.8% (electric hybrid bu...
Upgrades •$阿卡迪亚(ACAD.US)$: Jefferies Upgrades to Buy from Hold - PT $25 (from $22) •$亚瑟加拉格尔(AJG.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182) •$Apple Hospitality REIT(APLE.US)$: B.Riley Upgrades to Buy from Neutral - PT $19 •$汽车地带(AZO.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125) •$波音(BA.US)$: Citigroup Upgr...
莎莉美容控股公司股票讨论区
2023Q1营收增长0.8%,营业利润下滑9%,净利润下滑12.7%。
目前市盈率7.4,市盈率TTM提高到8.4,考虑到不断萎缩的财务数据,暂时缺乏吸引力。
• $铿腾电子(CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $Federated Hermes(FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $高盛(GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $麦当劳(MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $甲骨文(ORCL.US)$ : Exane Upg...
• $Akero Therapeutics(AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital(BRSP.US)$ +6.3% (increases dividend)
• $Humanigen(HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $艾里逊变速箱(ALSN.US)$ +2.8% (electric hybrid bu...
• $阿卡迪亚(ACAD.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $22)
• $亚瑟加拉格尔(AJG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182)
• $Apple Hospitality REIT(APLE.US)$ : B.Riley Upgrades to Buy from Neutral - PT $19
• $汽车地带(AZO.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125)
• $波音(BA.US)$ : Citigroup Upgr...
暂无评论